Ethyl 2-(4-hydroxyphenyl)-4-phenylthiazole-5-carboxylate, 250mg

(S)-5-(((tert-Butyldimethylsilyl)oxy)methyl)-1-(5-methoxy-2-nitro-4-((triisopropylsilyl)oxy)benzoyl)pyrrolidin-3-one, 250mg

3-Chloro-2-fluoro-4-iodopyridine, 95.0%, 25g

Sodium ammonium phosphate tetrahydrate, 99.0%, 500g

(S)-4-Phenyloxazolidine-2-thione, 95+%, 100mg

Volumetric flasks class A transparent, 100 ml, 14/23, 2 Piece(s)

(2-methylquinolin-5-yl)boronic acid hydrate, 95.0%, 250mg

2,7-Dichlorodihydrofluorescein diacetate, 97.0%, 1g

(2-Cyclopropyloxazol-5-yl)methanol, 95%, 100mg

6,7-Dihydro-4H-cyclopenta[d][1,2,4]triazolo[1,5-a]pyrimidin-8(5H)-one, 95%, 250mg

(S)-1-Cyclohexylethanamine, 98.0%, 1g

N-(5-Hydroxypyridin-2-yl)acetamide, 95.0%, 100mg

1-(4-Ethylphenyl)-3-(1H-indol-3-yl)urea, 97.0%, 5mg